Graney Thomas Insider Trades

Insider Trading History

Track insider trading activity for Graney Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Notable Labs
Notable Labs NTBL
Director
Holding Value $9.98k 40,247 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.9k 40,247 shares
$1.19
$0.25
Notable Labs
Notable Labs NTBL
Director
Holding Value $2.42k 9,753 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 9,753 shares
$1.28
$0.25
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Chief Financial Officer
Holding Value $5.32M 12,430 shares
Last Trade
Oct 01, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$208k 1,076 shares
$193.24
$428.34
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Chief Financial Officer
Holding Value $5.69M 13,289 shares
Last Trade
Feb 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.38M 14,936 shares
$159.27
$428.34
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Chief Financial Officer
Holding Value $3.76M 8,789 shares
Last Trade
Jan 02, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$117k 777 shares
$149.95
$428.34
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Chief Financial Officer
Holding Value $4.1M 9,566 shares
Last Trade
Sep 13, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 9,566 shares
$156.80
$428.34
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $413k 127,500 shares
Last Trade
Feb 27, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.14M 148,750 shares
$14.37
$3.24
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $71.9k 22,180 shares
Last Trade
Feb 22, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.2k 1,874 shares
$14.52
$3.24
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $340k 105,000 shares
Last Trade
Mar 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 122,500 shares
$8.78
$3.24
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $16.6k 5,137 shares
Last Trade
Feb 24, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.28k 563 shares
$7.61
$3.24
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $110k 34,100 shares
Last Trade
Mar 16, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$533k 39,800 shares
$13.38
$3.24
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals IRWD
Chief Financial Officer
Holding Value $486k 150,000 shares
Last Trade
Sep 02, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.26M 200,000 shares
$11.28
$3.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up